Skip to content

Customised viral vector manufacturing for cell and gene therapy

Who we are

BioViros is a full-service lentivirus producer, offering affordable,
customised viral vectors for cell and gene therapy with world class quality.

Cost effective

New Zealand based

World class quality

Recent Articles

EINPRESSWIRE - Article

Article
EINPRESSWIRE
March 2023

Herald Article

Article
National Business Review
February 2023

Founders Story - Lab Opening

Watch
Our Lab Opening
February 2023

Partnerships

Bridgewest Ventures Logo

Bridgewest Ventures

BioViros is proudly supported by Bridgewest Ventures NZ LP. Bridgewest Ventures is part of the Bridgewest Group and has a long track record of successfully incubating and launching major global innovation-led companies.

Bridgewest’s deep technology experience is wide-ranging and includes drug discovery and deep research into health technology, with expertise in novel CAR T-cell platforms.

Bridgewest Ventures leverage their extensive connections, international reach, and commercialisation experience to transform innovative opportunities into world-class companies.

Callaghan Innovation - Logo

Callaghan Innovation - Fostering Innovation in NZ

We are delighted to be part of Callaghan Innovation’s Technology Incubator Programme.


Callaghan Innovation is New Zealand’s innovation agency. It activates innovation and helps businesses grow faster for a better New Zealand. The government agency delivers a range of innovation and R&D services to suit each stage of business growth.

Callaghan Innovation staff, including more than 200 of New Zealand’s leading scientists and engineers, empower innovators by connecting people, opportunities, and networks and providing tailored technical solutions, skills and capability development programmes, and grants co-funding.

Why Us?

Experience

Years of accumulated knowledge in viral vector development and manufacturing

Quality

Strict quality control measures to ensure consistency and purity of viral vectors

Cost-effective

Competitive pricing for high quality and consistent results
 

Scalability

Process development for large-scale production of viral vectors
 

Customization

Customizations to specific requirements for specific tropism or a specific packaging system
 
 

Speed

Fast turnaround time from first contact to meet our customers timelines

Agility

Customer focused with a range of production batch scales
 
 
 

Transparency

Regular updates and communication throughout the development and production process
 
 
 

Choose a dynamic partner

We want to provide patients worldwide with easy access to affordable treatments for cancers and genetic disorders.

We specialise in customized lentiviral vectors production and purification for cell and gene therapy. 

How?

BioViros team counts years of experience in cell biology, CAR-T therapy, virus production, biologics purification and science commercialisation. Supported by Bridgewest Ventures and Callaghan Innovation, we strive to innovate and improve lentivirus vector manufacturing, and make the bench to bed journey faster and cheaper for people that need life-saving treatments, while keeping the high-quality standards.